Author

Richard Melsheimer 1

1 Janssen Biologics Medical Affairs,Leiden,Netherlands

EARLY DOSE OPTIMIZATION IN NONRESPONDERS TO GOLIMUMAB INDUCTION TREATMENT FOR ULCERATIVE COLITIS IS SUPPORTED BY PHARMACOKINETIC DATA THROUGH 1 YEAR

George Philip, Colleen W. Marano, Omoniyi J. Adedokun, Richard Melsheimer, Freddy Cornillie

Item 1 - 1 / 1
1